Scilex Holding (SCLX) Net Cash Flow (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Net Cash Flow of $1.1 million for Q1 2026, down 57.12% year-over-year from $2.5 million in Q1 2025, and down 77.57% on a QoQ basis from $4.8 million in Q4 2025.

Scilex Holding (SCLX) Net Cash Flow (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Net Cash Flow for 7 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Cash Flow fell 57.12% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $995000.0 (down 67.12% YoY), while the FY2025 annual figure was $2.4 million, up 267.4% from the prior year.
  • Net Cash Flow came in at $1.1 million for Q1 2026 at Scilex Holding, down from $4.8 million in the prior quarter.
  • The five-year high for Net Cash Flow was $30.1 million in Q2 2023, with the low at -$33.1 million in Q3 2023.
  • Average Net Cash Flow over 5 years is $144529.4, with a median of -$299000.0 recorded in 2022.
  • The largest YoY upside for Net Cash Flow was 9813.22% in 2022 against a maximum downside of 11419.18% in 2022.
  • Year by year, Net Cash Flow stood at -$299000.0 in 2022, then surged by 1019.4% to $2.7 million in 2023, then tumbled by 276.21% to -$4.8 million in 2024, then jumped by 199.77% to $4.8 million in 2025, then tumbled by 77.57% to $1.1 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered $1.1 million, $4.8 million, and -$3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -2.05 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.00 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 4.17 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -1.53 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -9.27 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 75.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 544.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 1.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Mn
Mar 31, 2026 1.08 Mn
Dec 31, 2025 4.83 Mn
Dec 31, 2025 4.83 Mn
Sep 30, 2025 -3.26 Mn
Sep 30, 2025 -3.26 Mn
Jun 30, 2025 -1.66 Mn
Jun 30, 2025 -1.66 Mn
Mar 31, 2025 2.53 Mn
Mar 31, 2025 2.53 Mn
Dec 31, 2024 -4.84 Mn
Dec 31, 2024 -4.84 Mn
Sep 30, 2024 -1.55 Mn
Sep 30, 2024 -1.55 Mn
Jun 30, 2024 6.89 Mn
Jun 30, 2024 6.89 Mn
Mar 31, 2024 -1.96 Mn
Mar 31, 2024 -1.96 Mn
Dec 31, 2023 2.75 Mn
Dec 31, 2023 2.75 Mn